Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mustafa Khasraw
Duke University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Campbelltown Hospital
Campbelltown, New South Wales, Australia
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- Newcastle Private Hospital
New Lambton Heights, New South Wales, Australia
- Port Macquarie Hospital
Port Macquarie, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
- Wollongong Hospital
Wollongong, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Icon Cancer Centre
South Brisbane, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Epworth Healthcare
Richmond, Victoria, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Duke University Medical Center
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Feb 2018
- Primary completion
- 28 Jun 2024
- Completion
- 31 Dec 2025
- Last update posted
- 11 Dec 2024
- Registered enrollment
- 103
- Registry id
- NCT04195139
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.